Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.
Your search for comorbidities returned 17 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers sought to determine whether the stress of a contentious political election increases the risk of arrhythmia in patients with known susceptibility.
A systematic review and meta-analysis was conducted to look at the effects of body mass index on atrial fibrillation‐related outcomes in anticoagulated patients.
Sodium-glucose cotransporter 2 inhibitors use may reduce cardiac arrhythmia risk, including the risk for atrial fibrillation.
In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation may increase the risk of in-hospital mortality.
Patients with atrial fibrillation who use anticoagulants and have a history of gastrointestinal bleeding may be at higher risk for subsequent major gastrointestinal bleeding.
The risk for a cardiac event was found to be greater in patients with peripheral artery disease vs coronary artery disease.
Left atrial enlargement with vs without atrial fibrillation was not found to be associated with greater cognitive decline over a 5-year period.
Researchers investigated and compared the rates, risks, and risk factors for atrial fibrillation among Medicaid recipients with systemic lupus erythematosus (SLE) and age- and sex-matched Medicaid recipients without SLE.
Advanced interatrial block is a favorable parameter to estimate the presence of low voltage area and it may provide useful information for the treatment strategy for atrial fibrillation and the prediction of the outcome after ablation.